Dr. Paula N. Goldman

A proud alumnus of the University of Michigan’s College of LS&A and Medical School, Dr. Bravender trained in Pediatrics at Duke University, Adolescent Medicine at Boston Children’s Hospital, received his MPH from Harvard University, and has held faculty appointments at the aforementioned Harvard and Duke. After decades away, he was delighted to return home to Ann Arbor in 2014 to establish the Division of Adolescent Medicine in the Department of Pediatrics. He is currently the David S Rosen MD Collegiate Professor of Adolescent Medicine and Clinical Professor of Pediatrics and Psychiatry. In addition to his academic appointments, he serves as Associate Chair for Faculty Affairs in the Department of Pediatrics, Division Director of Adolescent Medicine, executive director of the Mott Comprehensive Eating Disorders Program, and co-medical director of the University of Michigan Adolescent Health Initiative. Dr. Bravender is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Anorexia, Malnutrition, Bulimia, and Protein Deficiency. Dr. Bravender is board certified in Pediatrics and Adolescent Medicine.

Kelly Walkovich is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Walkovich is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Infantile Neutropenia, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Dr. Steven Pipe is a Professor and the Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology at the University of Michigan, Ann Arbor, Michigan, USA. He is the medical director of the Pediatric Hemophilia and Coagulation Disorders Program and medical director of the Special Coagulation Laboratory. His clinical interests include bleeding and thrombotic disorders and congenital vascular anomalies. Dr Pipe also directs a basic research lab investigating coagulation factor VIII and the molecular mechanisms of hemophilia A. He has been actively involved in clinical trials with novel therapeutics for hemophilia including gene therapy. He was the 2015 recipient of the Leadership in Research Award from the National Hemophilia Foundation. He has served on the Board of Directors for the Hemostasis and Thrombosis Research Society, as Chair of the Board of Directors for the American Thrombosis and Hemostasis Network and currently as Chair of the Medical and Scientific Advisory Committee to the National Hemophilia Foundation. Dr. Pipe is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilia B, Blood Clots, and Von Willebrand Disease (VWD).